Co-Administration of a Thrombolytic and an Anti-CD18 Antibody in Stroke
A method for improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size is described which involves administering an effective amount of an anti-CD18 antibody to the mammal, in the absence of removal of the arterial obstruction.
BEDNAR MARTIN M [US]; GROSS CORDELL E [US]; GROSS LINDA J [US]; THOMAS G ROGER [US]
Type of Offer:
« More Biotech Patents